TABLE 1.
Sample types and testing for diagnosis of congenital and maternal CMV infectiona
| Sample type | Method | Timing of evaluation | Sens/Spec | Comments | References |
|---|---|---|---|---|---|
| Diagnosis of maternal primary CMV infection | |||||
| Serum | Serology: CMV IgG | <16 weeks’ gestation | 97%–100%/96%–100% |
|
(10) |
| CMV IgM | 54%–100%/62%–100% |
|
(10–17) | ||
| CMV IgG avidity | 85%/>90% |
|
(18, 19) | ||
| Diagnosis of congenital CMV in the fetus | |||||
| Amniotic fluid | NAAT | 6 weeks after maternal infection >21 weeks’ gestation |
90%–95%/99% |
|
(8, 20) |
| Chorionic villi, umbilical cord blood | NAAT | NA | ND |
|
(21–23) |
| Diagnosis of congenital CMV in infant or older child | |||||
| Urine | NAAT | <3 weeks old | 98.8%–100.0%/99% |
|
(24, 25) |
| Saliva | NAAT | <3 weeks old | 97.4%–100.0%/91.5%–99.9% |
|
(26, 27) |
| Dried blood spotb | NAAT | >3 weeks old | 34.4%–76.8%/99.9% |
|
(28, 29) |
| Blood, viral load | NAAT | <3 weeks old | ND |
|
(26, 30) |
| Serum | Serology CMV IgG CMV IgM |
NA | ND |
|
(31, 32) |
NA, not available; NAAT, nucleic acid amplification testing; ND, not detected; Sens, sensitivity; Spec, specificity.
Sample collected at birth.